Quality of Life in elderly patients with cancer

par Perrone Francesco, Di Maio Massimo
Publié 2003-09-01

Quality of Life in elderly patients with cancer

par Di Maio, Massimo, Perrone, Francesco
Publié 2003

A review of guidelines for lung cancer

par Bironzo, Paolo, Di Maio, Massimo
Publié dans J Thorac Dis (2018)

Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

par Metro, Giulio, Di Maio, Massimo
Publié dans Transl Lung Cancer Res (2018)

Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

par Metro, Giulio, Di Maio, Massimo
Publié dans Transl Lung Cancer Res (2018)

The lesson learned from figitumumab clinical program and the hope for better results in squamous lung cancer

par Di Maio, Massimo, Scagliotti, Giorgio Vittorio
Publié dans Transl Lung Cancer Res (2015)

Real‐World Evidence in Oncology: Opportunities and Limitations

par Di Maio, Massimo, Perrone, Francesco, Conte, Pierfranco
Publié dans Oncologist (2019)

Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

par Facchinetti, Francesco, Di Maio, Massimo, Tiseo, Marcello
Publié dans Cancers (Basel) (2020)

Raising the bar for enthusiasm when looking at results of randomized phase II trials—the case of sunitinib in small-cell lung cancer

par Di Maio, Massimo, Bironzo, Paolo, Scagliotti, Giorgio Vittorio
Publié dans Transl Lung Cancer Res (2016)

Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence

par De Luca, Emmanuele, Marino, Donatella, Di Maio, Massimo
Publié dans Cancer Manag Res (2020)

The KEY for chemo-immunotherapy combination: taking NOTEs from squamous cell lung cancer

par Reale, Maria Lucia, De Luca, Emmanuele, Di Maio, Massimo
Publié dans Transl Lung Cancer Res (2020)

COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice

par Marandino, Laura, Necchi, Andrea, Aglietta, Massimo, Di Maio, Massimo
Publié dans JCO Oncol Pract (2020)

First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis

par Facchinetti, Francesco, Di Maio, Massimo, Perrone, Fabiana, Tiseo, Marcello
Publié dans Transl Lung Cancer Res (2021)

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-...

par Addeo, Alfredo, Banna, Giuseppe Luigi, Metro, Giulio, Di Maio, Massimo
Publié dans Front Oncol (2019)

Second-line treatment options in hepatocellular carcinoma

par Marino, Donatella, Zichi, Clizia, Audisio, Marco, Sperti, Elisa, Di Maio, Massimo
Publié dans Drugs Context (2019)

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis

par Guaitoli, Giorgia, Tiseo, Marcello, Di Maio, Massimo, Friboulet, Luc, Facchinetti, Francesco
Publié dans Transl Lung Cancer Res (2021)

Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase Inhibitors

par Zwitter, Matjaz, Rossi, Antonio, Di Maio, Massimo, Perme, Maja Pohar, Lopes, Gilberto
Publié dans Radiol Oncol (2017)

BRAF-mutated metastatic colorectal cancer between past and future

par Cremolini, Chiara, Di Maio, Massimo, Petrelli, Fausto, Berenato, Rosa, Loupakis, Fotios, Pietrantonio, Filippo
Publié dans Br J Cancer (2015)

Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic

par Fratino, Lucia, Procopio, Giuseppe, Di Maio, Massimo, Cinieri, Saverio, Leo, Silvana, Beretta, Giordano
Publié dans Front Oncol (2020)

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions

par Tucci, Marcello, Zichi, Clizia, Buttigliero, Consuelo, Vignani, Francesca, Scagliotti, Giorgio V, Di Maio, Massimo
Publié dans Onco Targets Ther (2018)